These findings underscore the need for careful consideration of KD use in individuals at elevated risk for pancreatic cancer.<h4>Significance</h4>This article evaluates the impact of KDs and HFDs prior to oncogenic Kras activation in the AcinarKrasG12V model. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.